Maven Securities’s Boston Scientific BSX Stock Holding History

Maven Securities’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,900	Closed	-$526K	–	495
2025 Q2	$526K	Buy	+4,900	New	+$496K	0.01%	592
2024 Q1	–	Sell	-6,000	Closed	-$347K	–	439
2023 Q4	$347K	Sell	6,000 -69,000	-92%	-$3.68M	0.01%	769
2023 Q3	$3.96M	Buy	+75,000	New	+$3.93M	0.04%	235
2023 Q2	–	Sell	-7,300	Closed	-$365K	–	879
2023 Q1	$365K	Sell	7,300 -5,200	-42%	-$245K	0.01%	743
2022 Q4	$578K	Sell	12,500 -700	-5%	-$30.3K	0.01%	553
2022 Q3	$511K	Buy	+13,200	New	+$530K	0.01%	782
2022 Q2	–	Sell	-13,400	Closed	-$593K	–	903
2022 Q1	$593K	Sell	13,400 -46,800	-78%	-$2.03M	0.02%	492
2021 Q4	$2.56M	Buy	60,200 +44,400	+281%	+$1.87M	0.07%	152
2021 Q3	$686K	Buy	+15,800	New	+$699K	0.02%	562

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Maven Securities's BSX Position: Q3 2022 in Review

Maven Securities sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 12,412 shares — an estimated $498K sold.

Maven Securities first reported a position in BSX in Q2 2020 and held it in 5 quarters. The position peaked at $2.34M in Q4 2020. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

Maven Securities reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
Maven Securities sold 12,412 Boston Scientific shares in Q3 2022, an estimated $498K.
Maven Securities first reported a position in Boston Scientific in Q2 2020 and held it in 5 quarters.
Maven Securities's Boston Scientific position peaked at $2.34M in Q4 2020.
864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Maven Securities's 13F filing for Q3 2022, filed 14 Nov 2022.